You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood lymphocyte depletion Hodgkin lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity

Completed
Has Results
  • Childhood Favorable Prognosis Hodgkin Lymphoma
  • +5 more
  • radiation therapy
  • +11 more
  • Arcadia, California
    Children's Oncology Group
Mar 26, 2021

Quality of Life in Adult and Pediatric Nodular

Recruiting
  • Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    • Aurora, Colorado
    • +1 more
    Oct 27, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    Non-hodgkin Lymphoma,B Cell Trial (CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection)

    Not yet recruiting
    • Non-hodgkin Lymphoma,B Cell
    • CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
    • (no location specified)
    Feb 14, 2023

    Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular

    Not yet recruiting
    • Nodular Lymphocyte Predominant Hodgkin Lymphoma
    • +2 more
    • Biopsy
    • +9 more
    • (no location specified)
    Jun 1, 2023

    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

    Active, not recruiting
    • Adult Lymphocyte Depletion Hodgkin Lymphoma
    • +16 more
    • 6,8-bis(benzylthio)octanoic acid
    • bendamustine hydrochloride
    • Winston-Salem, North Carolina
    • +1 more
    Apr 8, 2022

    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

    Completed
    Has Results
    • Adult Lymphocyte Depletion Hodgkin Lymphoma
    • +5 more
    • gemcitabine hydrochloride
    • bendamustine hydrochloride
    • Atlanta, Georgia
    • +1 more
    Oct 21, 2021

    Leukemia, Stem Cell Transplantation Trial in Munich (FBTA05)

    Withdrawn
    • Leukemia
    • Stem Cell Transplantation
    • Munich, Bavaria, Germany
      3. Medizinische Klinik, Klinikum rechts der Isar der TU München
    Dec 5, 2022

    Hodgkin Lymphoma Trial in Latakia (First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3

    Recruiting
    • Hodgkin Lymphoma
    • First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3 and third analysis: Lymphocyte/Monocyte ratio > or = 2.9
    • First analysis: Lymphocyte count < 1500 cells per microlitre, second analysis: IPS > or = 3 and third analysis: Lymphocyte/Monocyte ratio < 2.9
    • Latakia, Syrian Arab Republic
      Tishreen University
    Feb 14, 2022

    Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

    Active, not recruiting
    • Refractory Non Hodgkin Lymphoma
    • Relapsed Non Hodgkin Lymphoma
    • rituximab
    • +7 more
    • Sacramento, California
      University of California Davis
    Nov 28, 2022

    Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Low-field magnetic resonance imaging
    • +3 more
    • Erlangen, Bavaria, Germany
      Department of Pediatrics and Adolescent Medicine
    Oct 23, 2023

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Classic Hodgkin Lymphoma Trial in

    Recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +9 more
    • Anti-CD30/CD16A Monoclonal Antibody AFM13
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)

    Active, not recruiting
    • Multiple Myeloma
    • +4 more
    • Total Body Irradiation
    • +5 more
    • Los Angeles, California
      Cedars Sinai Medical Center
    Dec 21, 2022

    Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,

    Recruiting
    • Childhood Non-Hodgkin Lymphoma
    • +2 more
    • Goal Management Training (GMT)
    • Brain Health Workshop (BHW)
    • Oslo, Norway
    • +2 more
    May 25, 2022

    Frailty in Young Adult Survivors of Childhood Cancer

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jul 8, 2022

      ADLs at End of Acute Treatment for Childhood Leukemia and

      Enrolling by invitation
      • Childhood Cancer
      • Assessment of the accomplishment regarding Activities of Daily Living at the end of acute treatment
      • Munich, Germany
        Kinderklinik München Schwabing, TUM School of Medicine, Departme
      May 9, 2022

      Cognitive Impairment in Young Patients With Cancer Prospectively

      Recruiting
      • Chemotherapy-Related Cognitive Impairment
      • +9 more
        • Copenhagen, Denmark
          Rigshospitalet
        Apr 24, 2023

        ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)

        Not yet recruiting
        • ALL
        • +3 more
        • Transcranial photobiomodulation (tPBM) - Mobile System
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Dec 6, 2022

        Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

        Recruiting
        • Recurrent Childhood Acute Myeloid Leukemia
        • +17 more
          • Miami, Florida
            Nicklaus Children's Hospital
          May 13, 2023

          Ex Vivo Drug Sensitivity Testing and Mutation Profiling

          Completed
          • Recurrent Childhood Acute Myeloid Leukemia
          • +13 more
            • Miami, Florida
              Nicklaus Children's Hospital
            Jan 18, 2023

            Lymphoma Trial in Giessen (drug, other, procedure)

            Active, not recruiting
            • Lymphoma
            • Giessen, Germany
              Universitaetsklinikum Giessen-Marburg
            May 10, 2021

            Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Trial in Cologne (Ibrutinib)

            Completed
            • Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
            • Cologne, Germany
              1st Department of Medicine, Cologne University Hospital
            Apr 6, 2021

            Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

            Recruiting
            • Acute Myeloid Leukemia
            • +6 more
            • boost anti-viral immunity after T-cell depleted HSCT
            • Moscow, Russian Federation
              Federal Research Center for pediatric hematology, oncology and i
            Oct 1, 2021

            B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

            Recruiting
            • B-cell Acute Lymphoblastic Leukemia
            • B-cell Non Hodgkin Lymphoma
            • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
            • Aurora, Colorado
              Children's Hospital Colorado
            Nov 9, 2022

            Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

            Active, not recruiting
            • Acute Lymphoid Leukemia (ALL)
            • +5 more
            • Hyperfractionated total body irradiation
            • +9 more
            • New York, New York
              Memorial Sloan Kettering Cancer Center
            Jan 21, 2022